Popular Articles
Teeth Whitening Products

Best Clinical Management For H5N1 Infection Debated
The best ways of managing patients with H5N1 infection (avian influenza)
generic viagra online
Prevention Program Helps Teens Override A Gene Linked To Risky Behavior
A family-based prevention program designed to help adolescents avoid substance use and other risky behavior proved especially effective for a group of young teens with a genetic risk factor contributing toward such behavior, according to a new study by researchers at the University of Georgia. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), components of the National Institutes of Health, supported the study, which appears in the May/June issue of Child Development.
News of the day
CMA Applauds Senate Passage Of FDA Tobacco Rules
The California Medical Association supports the passage of the Family Smoking Prevention and Tobacco Control Act that would allow the U.S. Food and Drug Administration to finally set standards for cigarettes and regulate chemicals. In 1963, CMA was the first among state medical societies to create policy to inform people about the harmful effects of cigarette smoking.
Oncology

Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)

The latest issue of the online journal Diabetic Hypoglycemia features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy. Professor Campbell"s review focuses on sulfonylurea-induced hypoglycemia (SIH), which is a well-recognized side-effect of this class of therapy for type 2 diabetes. In the review he discusses the incidence of SIH, with particular reference to the different sulfonylureas. He also reflects on the morbidity and mortality seen with SIH, precipitating risk factors, treatment of SIH, and education of patients and medical staff in the prevention of SIH. This issue of Diabetic Hypoglycemia also includes a case study on recurring hypoglycemia associated with glibenclamide, by Professor Campbell. Dr Rory McCrimmon of the Editorial Board reviews the literature on blood glucose monitoring in hypoglycemia, in an editorial entitled "What we"re learning from continuous glucose monitoring". This issue of Diabetic Hypoglycemia also features an "In profile" interview with Professor Stephanie Amiel, a leading expert in the use of neuroimaging in diabetes and hypoglycemia. About the Journal Diabetic Hypoglycemia is an influential online diabetes journal. The Editorial Board of hypoglycemia experts peer review all Journal content. The Board is led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA) and Dr Rory McCrimmon (Yale, USA). Diabetic Hypoglycemia is published three times a year, providing an interactive forum for readers to share practical knowledge and opinions on the rapidly evolving field of hypoglycemia. To explore the Diabetic Hypoglycemia website and its key features, our guided tour can be activated by clicking the following link here. Diabetic Hypoglycemia is published by ESP Bioscience. Support for the journal is provided by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark). ESP Bioscience


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):